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Background  and  purpose      Following  metal-on-metal  hip 
arthroplasty (THA), immunological reactions including changes 
in lymphocyte populations, aseptic loosening, and lymphocytic 
pseudotumors occur. We hypothesized that changes in lympho-
cyte subpopulations would be associated with elevated metal ion 
concentrations.
Methods   A randomized trial involving 85 patients matched for 
age and sex and randomized to receiving metal-on-metal (n = 41) 
or metal-on-polyethylene total hip arthroplasty (n = 44) was con-
ducted. 36 patients were eligible for follow-up after mean 7 (6–8) 
years. Concentrations of chromium and cobalt were analyzed by 
high-resolution inductively coupled plasma mass spectrometry. 
Leukocyte subpopulations and immunoglobulins in patient blood 
were measured using standard laboratory methods.
Results   Patients with a metal-on-metal hip had higher serum 
concentrations of chromium (1.05 vs. 0.36 µg/L; p < 0.001) and 
cobalt (0.86 vs. 0.24 µg/L; p < 0.001) than those with metal-on-
polyethylene.  The  percentage  of  HLA  DR+  CD8+  T-cells  was 
higher in the metal-on-metal group (10.6 vs. 6.7%; p = 0.03) and 
correlated positively with chromium and cobalt concentrations 
in patient blood (Pearson’s correlation coefficient: 0.39, p = 0.02; 
0.36, p = 0.03, respectively). The percentage of B-cells was lower in 
the metal-on-metal group (p = 0.01). The two groups were similar 
with respect to immunoglobulin concentrations and Harris hip 
scores, and there were no radiographic signs of loosening.
Interpretation   We conclude that immunological alterations 
appear  to  be  associated  with  increased  cobalt  and  chromium 
concentrations. It is tempting to speculate that HLA DR+ CD8+ 
T-cells  are  involved  in  the  pathogenesis  of  allergic  reactions, 
implant loosening, and lymphocytic pseudotumors.
 
 
Immunological  phenomena—both  local  and  systemic—
that are attributed to elevated metal ion concentrations have 
been described after modern metal-on-metal arthroplasty: 1. 
Lymphocyte-mediated  inflammatory  reactions  occur  in  the 
vicinity  of  metal-on-metal  articulations,  and  polyethylene-
independent osteolysis has been characterized histologically 
in such cases (Davies et al. 2005, Willert et al. 2005, Lazarinis 
et al. 2008). 2. The development of periprosthetic soft-tissue 
masses containing large numbers of lymphocytes has been 
identified as a cause of persistent pain, especially in females, 
after metal-on-metal hip resurfacing (Pandit et al. 2008, Toms 
et al. 2008). 3. At the systemic level, the induction of delayed-
type  hypersensitivity  directed  against  metal  ions  has  been 
observed after metal-on-metal THA (Hallab et al. 2004). 4. A 
decrease in the amount of circulating CD8+ T-cells has been 
described in patients with elevated metal ion levels subsequent 
to metal-on-metal THA, indicating further systemic immuno-
logical effects (Hart et al. 2006, 2009).
We have recently published a study of patients who were 
randomized  to  receive  either  a  metal-on-polyethylene  or  a 
metal-on-metal bearing with a 28-mm metal head (Dahlstrand 
et al. 2009). Clinical parameters, radiology results, and con-
centrations of chromium, cobalt, nickel, and manganese were 
followed, and we found elevation of all metal ions after 2 
years in the metal-on-metal group. In the present study, we 
hypothesized that immunological changes can occur as a con-
sequence of elevated metal ion concentrations in the medium 
term. Specifically, in the light of previously published find-
ings, we expected changes in subsets of CD4+ or CD8+ lym-
phocytes, but no gross changes in other lymphocyte subpopu-
lations or in serum immunoglobulins.Acta Orthopaedica 2011; 82 (1): 6–12  7
Patients and methods
Study design and population
This prospective randomized study was performed in accor-
dance with the ethical standards of the Helsinki declaration. 
Informed consent was obtained from all patients and the study 
was approved by the local ethics committee (no. 2006/958). 
The primary endpoints of the study were (1) the determina-
tion  of  concentrations  of  the  heavy  metal  ions  chromium, 
cobalt, nickel, and manganese in patient blood and (2) implant 
migration  relative  to  surrounding  bone,  as  determined  by 
radiostereometry in 2 groups of patients that were random-
ized to receiving either a metal-on-metal bearing or a metal-
on-polyethylene bearing. The investigation of immunological 
parameters was added as a secondary endpoint for this study 
at a later stage.
166 patients, referred to the Department of Orthopedics, 
Karolinska  Hospital,  Sweden  because  of  osteoarthritis  of 
the hip, were eligible for study participation. Inclusion cri-
teria were pain due to radiographically verified osteoarthritis 
and age between 40 and 75 years. Exclusion criteria were 
refusal to participate in the study, previous surgery with either 
osteosynthesis or joint replacement, weight over 105 kg, pre-
vious infection or surgery in the affected hip, local or general 
osteoporosis,  intake  of  systemic  cortical  steroids  for  more 
than 3 months during the previous year, abuse of alcohol or 
drugs, and mental disorders including dementia. Strict appli-
cation of inclusion and exclusion criteria left a cohort of 85 
patients who were allocated to one of two groups according 
to the minimization method: 44 patients received a metal-on-
polyethylene  bearing  and  41  patients  received  a  metal-on-
metal bearing (Figure 1). The groups were matched accord-
ing to sex, smoking habits, body weight, and age. Neither the 
patients nor the authors involved were blinded as to the type 
of bearing; however, for determination of the Harris hip score, 
a physiotherapist blinded to the type of bearing collected the 
data. All patients were followed for 2 years, but 10 were sub-
sequently lost to follow-up. Furthermore, 39 patients had to 
be excluded from the analysis presented here because they 
had received additional metal implants, rendering the mea-
surement of metal ion concentrations meaningless. This left 
a study population of 36 patients, 19 in the metal-on-metal 
group and 17 in the metal-on-polyethylene group, who were 
followed for a mean of 82 (72–97) months.
Implants
In all patients, a matte, tapered stainless steel stem (MS30; 
Sulzer, Winterthur, Switzerland) with a modular 28-mm head 
was combined with a low-profile cup. Two types of bearings 
were used: one consisted of a wrought high-carbon, cobalt-
Figure 1. CONSORT flow chart.8  Acta Orthopaedica 2011; 82 (1): 6–12
chromium alloy head against a cobalt-chromium liner fitted 
in a polyethylene cup, making it a metal-on-metal bearing 
(Metasul; Sulzer). The other articulation was a similar cobalt-
chromium head (Protasul; Sulzer) against an all-polyethylene 
cup (Müller, Durasul; Sulzer). The alloy of the heads and liner 
consisted of a minimum of 50% cobalt, 26–30% chromium, 
7% molybdenum, 1% nickel, and 1% manganese. The Metasul 
head is more polished than the Protasul, in order to minimize 
friction against the metal liner. Stem and cup were cemented 
with Palacos with gentamicin (Heraeus, Hanau, Germany) in 
all cases. All procedures were performed through a standard 
posterior approach by the same senior surgeon (AS) between 
October 1998 and January 2001.
Clinical outcome measures and radiology 
The Harris hip score (HHS) was determined preoperatively 
and at follow-up visits 3, 6, 12, 24, and 72 months after sur-
gery. In all patients, follow-up included anteroposterior and 
lateral radiographs of the hip.
Analysis of ion concentrations in serum 
Samples of serum were collected from patients preoperatively 
and at 3, 6, 12, 24, and 72 months, in a standardized manner 
by a registered nurse using an 18-gauge intravenous cannula 
with the central stainless steel needle removed. The first 5 mL 
of blood drawn from each patient was discarded. The con-
tainers used were 10-mL polypropylene tubes with sodium 
heparin (Teklab Ltd., Durham, UK). One batch of cannulas 
and tubes was used throughout the study. All materials used to 
collect and store samples were chosen for their lack of metals 
investigated in this study.
The whole blood samples were centrifuged at 2,000 rpm for 
10 min; the serum was then transferred to acid-washed poly-
propylene storage tubes using disposable plastic pipettes and 
stored at –20°C until further analysis. All samples were subse-
quently sent to an accredited external laboratory specialized in 
trace metal analysis and analyzed for concentrations of cobalt 
and chromium by high-resolution inductively coupled plasma 
mass  spectrometry  using  a  commercially  available  device 
(Element;  Finnigan-MAT,  Bremen,  Germany).  The  detec-
tion limit for chromium was 0.2 µg/L (4 nMol/L) and that for 
cobalt was 0.05 µg/L (0.8 nMol/L). To facilitate comparisons 
with previous literature, ion concentrations are presented as 
mean concentrations in µg/L with 95% confidence intervals 
(CIs).
Immunological analysis
Leukocyte subpopulations were investigated by flow cytom-
etry on a Coulter EPICS-XL-MCL using commercially avail-
able antibodies (CD3, CD8, CD45, CD4: Tetracrome Beckman 
Coulter, Bromma, Sweden cat. no. 6607013; CD3, CD16/56, 
CD45, CD19: Tetracrome cat. no. 6607073 and Becton-Dick-
inson cat. no. 332779; HLA DR: Becton-Dickinson cat. no. 
6604366;  CD4:  Becton-Dickinson  cat.  no.  345768;  CD8: 
Dako cat. no. C7079). Results are given as numbers per nL, 
or as percentages. Immunoglobulins and IgG subclasses were 
analyzed by nephelometry (DADE Behrings BNll); subclasses 
were  determined  using  a  commercially  available  kit  (The 
Binding Site Group Ltd., Birmingham, UK) and the results 
are expressed in g/L.
Statistics
Before the study, a power analysis indicated that 20 patients 
per group would be sufficient to detect differences in metal 
ion  concentrations  (our  primary  endpoint)  of  one  standard 
deviation with a power of 80%, given a two-tailed p-value 
of 0.05. The investigation of immunological parameters was 
not planned at the onset of the study, but was deemed to be 
relevant at a later stage. Thus, the power estimation was not 
based on this secondary endpoint. In addition, a large number 
of  patients  had  to  be  excluded  from  follow-up  due  to  the 
implantation of a contralateral THA, which rendered analysis 
of metal ion concentrations meaningless.
All variables were summarized using standard descriptive 
statistics such as frequencies, means, medians, and standard 
deviations. The distributions of metal ion concentrations were 
severely positively skewed; i.e., most subjects were found at 
the lower ends of concentration ranges, contrasted by outliers 
with high concentrations. By calculation of the natural loga-
rithms of metal ion concentrations, they were transformed to 
normal distributions and metal ion concentrations were there-
fore subsequently analyzed using a linear model with cobalt 
or chromium concentrations after 6 years as the dependent 
variable, the type of bearing as the fixed factor, and preopera-
tive cobalt or chromium concentrations as a covariate. Model 
residuals  were  normally  distributed,  and  Cook’s  distances 
were < 1. Most immunological parameters were normally dis-
tributed, but baseline data were not available for these param-
eters; thus, inter-group comparisons of immunological param-
eters were performed using the independent t-test. Correlation 
analysis of logarithmically transformed metal ion concentra-
tions with immunological parameters was performed using 
Pearson’s  correlation  coefficient.  The  level  of  significance 
(two-tailed) was 0.05 in all analyses.
Results
Clinical and radiographic outcome
The two groups of patients did not differ with respect to age, 
sex, or BMI. Preoperatively, the HHS was 39 (CI: 32–46) in the 
metal-on-polyethylene group and 36 (CI: 31–41) in the metal-
on-metal group. At 6 years, the HHS was 94 (CI: 89–100) in 
the metal-on-polyethylene group and 90 (CI: 82–98) in the 
metal-on-metal group.
The radiographs obtained at follow-up did not show signs 
of liner wear, periprosthetic osteolysis, or implant loosening 
in any patient.Acta Orthopaedica 2011; 82 (1): 6–12  9
Concentrations of chromium and cobalt were sig-
nificantly elevated 6 years after metal-on-metal 
arthroplasty
Preoperatively, the concentration of chromium was low and 
mostly below the detection limits in both groups (Figure 2). 
In  the  metal-on-polyethylene  group,  the  mean  chromium 
concentration was 0.31 µg/L (CI: 0.20–0.42), and it was 0.32 
µg/L (CI: 0.22–0.42) in the metal-on-metal group. Postopera-
tively, the chromium concentrations increased substantially in 
the metal-on-metal group with a mean chromium concentra-
tion of 1.05 µg/L (CI: 0.53–1.6) after 6 years. In the metal-
on-polyethylene  group,  the  mean  chromium  concentration 
postoperatively showed no increase; after 6 years it was 0.36 
µg/L (CI: 0.15–0.58). The chromium concentrations measured 
in the metal-on-metal group were substantially higher after 6 
years than those measured in the metal-on-polyethylene group 
(p < 0.001). Baseline chromium concentrations made a minor 
but statistically significant contribution to the linear model 
(p = 0.05).
The concentration of cobalt was low preoperatively in both 
groups (Figure 3). The mean cobalt concentration was 0.16 
µg/L (CI: 0.1–0.23) in the metal-on-polyethylene group and 
0.09 µg/L (CI: 0.06–0.12) in the metal-on-metal group. 6 years 
after the index procedure, the mean concentration of cobalt 
showed a robust increase to 0.86 µg/L (CI: 0.49–1.22) in the 
metal-on-metal group. In the metal-on-polyethylene group, no 
relevant increase occurred (0.24 µg/L (CI: 0.12–0.36)). After 6 
years, cobalt concentrations were higher in the metal-on-metal 
group than in the metal-on-polyethylene group (p < 0.001). 
Baseline cobalt concentrations made no statistically signifi-
cant contribution to the linear model (p = 0.9).
Number of HLA DR+ CD8+ T-cells
The number of leukocytes per nL was similar in the 2 groups 
of bearing types: 6.8 in the metal-on-polyethylene group and 
6.4 in the metal-on-metal group (Table 1). The mean number 
of lymphocytes per nL was 1.9 in both groups. The concen-
trations of different subsets of lymphocytes (CD3+ T-cells, 
CD19+ B-cells, and CD16+/CD56+ NK-cells) were also simi-
lar in the 2 groups. However, a lower proportion of B-cells 
was found in the metal-on-metal group (9.3% vs. 12.9% in the 
metal-on-polyethylene group; p = 0.01).
T-cells were further differentiated into CD4+ T-(helper) cells 
and CD8+ T-(cytotoxic) cells, but there were no statistically 
significant differences between the two bearing groups. The 
Figure 3. Cobalt concentrations in serum prior to and 6 years after hip 
arthroplasty. Mean and 95% confidence intervals of cobalt concentra-
tions (in µg/L).
Figure 2. Chromium concentrations in serum prior to and 6 years after 
hip arthroplasty. Mean and 95% confidence intervals of chromium con-
centrations (in µg/L).
Table 1. Cellular immunological parameters. Mean differences in 
numbers  of  leukocytes,  lymphocytes,  or  lymphocyte  subpopu-
lations per nL, or percentages of lymphocytes, between the two 
bearing groups. Positive differences indicate higher values in the 
metal-on-metal group; negative differences indicate lower values in 
the metal-on-metal group
  Mean  95% confidence  p-value a
  difference  interval
Leukocytes   –0.4  –1.3–0.5  0.4
Lymphocytes  0.1  –0.4–0.5  0.8
T-cells CD3  0.0  –0.4–0.4  0.9
T-cells CD3 (%)  0.8  –4.6–6.2  0.8
T-cells CD4  0.0  –0.3–0.2  0.7
T-cells CD4 (%)  –3.1  –9.5–3.3  0.3
T-cells CD4 HLA DR+   1.5  –1.3–4.2  0.3
T-cells CD8   0.1  –0.1–0.3  0.4
T-cells CD8 (%)   5.0  –1.6–11.5  0.1
T-cells CD8 HLA DR+   3.9    0.3–7.4  0.03
CD4/CD8 ratio   –1.9  –4.8–1.1  0.2
B-cells CD19   0.0  –0.1–0.0  0.2
B-cells CD19 (%)   –3.7  –6.5–  -0.9  0.01
NK-cells CD16/CD56   0.1    0.0–0.2  0.1
NK-cells CD16/CD56 (%)   3.2  –1.8–8.3  0.2
a derived from independent t-test.10  Acta Orthopaedica 2011; 82 (1): 6–12
mean CD4/CD8 ratio was 4.7 in the metal-on-polyethylene 
group and 2.8 in the metal-on-polyethylene group. There were 
5.1% HLA DR+ CD4+ T-cells in the metal-on-polyethylene 
group, as compared to 6.5% in the metal-on-metal group. A 
statistically  significant  difference  between  the  two  bearing 
groups was, however, found in the population of CD8+ T-cells 
positive for the HLA DR-antigen: 6.7% CD8+ T-cells were 
HLA DR+ in the metal-on-polyethylene group, as compared 
to 10.6% in the metal-on-metal group (p = 0.03).
A  separate  statistical  analysis  was  done  after  stratifying 
the population for sex, but no significant differences between 
groups were found (data not shown).
Correlation of HLA DR+ T-cells with chromium con-
centrations
Correlation analysis showed that there was a positive correla-
tion between the percentage of HLA DR+ CD8+ T-cells and 
logarithmically transformed chromium and cobalt concentra-
tions after 6 years (Figure 4 and Table 2). We also found a neg-
ative correlation between the CD4/CD8 ratio and logarithmi-
cally transformed cobalt concentrations, but no other cellular 
immunological parameters showed any statistically significant 
correlation with the concentration of either ion. Logarithmi-
cally transformed cobalt and chromium concentrations after 
6 years showed a strong positive correlation with each other 
(Figure 4, Table 2; supplementary data).
No effects of elevated metal ion concentrations on 
the humoral immune response
The concentrations of the immunoglobulins IgG (and sub-
groups 1–4), IgM, and IgA were similar in both groups of 
patients (Table 3; see supplementary data). Furthermore, there 
were no correlations between immunoglobulin concentrations 
and logarithmically transformed cobalt or chromium concen-
trations (Table 4; see supplementary data).
Discussion
The main findings of our study are that: (1) serum concen-
trations of chromium and cobalt were elevated 6 years after 
metal-on-metal THA; (2) the proportion of HLA DR+ CD8+ 
T-cells was higher in patients who underwent metal-on-metal 
THA; (3) there was a positive correlation between the propor-
tion of HLA DR+ CD8+ T-cells and both chromium and cobalt 
concentrations; and (4) the percentage of B-cells was reduced 
in the metal-on-metal group.
Increased proportion of HLA DR+ CD8+ T-cells after 
metal ion exposure
Our finding that the percentage of HLA DR+ CD8+ T-cells 
was higher in patients with a metal-on-metal bearing has not 
been reported before. Against the background of the previ-
ously  described  reduction  in  the  total  population  of  CD8+ 
T-cells (Hart et al. 2006, 2009), a decrease in the number of 
HLA DR+ CD8+ T-cells could have been anticipated. How-
ever, in contrast to the data described by Hart et al., we found 
no reduction in the number of CD8+ T-cells in patients who 
underwent metal-on-metal THA. This discrepancy could be 
explained by differences between the various study settings. 
Our trial was randomized, the two groups of patients in our 
study were matched for age and sex, and there were no differ-
ences in BMI or time to follow-up between the two groups. In 
contrast, Hart et al. performed a retrospective review of a het-
erogeneous population; the groups investigated differed in sex 
distribution, age, BMI, and length of follow-up. The findings 
Figure 4. Correlation between the percentage of HLA DR+ CD8+ T-cells and metal ion concentrations after 6 years. A. A positive correlation was 
found between the percentage of HLA DR+ CD8+ T-cells and logarithmically transformed chromium concentrations after 6 years (Pearson’s cor-
relation coefficient: 0.39, p = 0.02). B. A positive correlation was also found between the percentage of HLA DR+ CD8+ T-cells and logarithmically 
transformed cobalt concentrations after 6 years (Pearson’s correlation coefficient: 0.36, p = 0.03). C. Logarithmically transformed cobalt and 
chromium concentrations were almost linearly correlated with each other (Pearson’s correlation coefficient: 0.85, p < 0.001).
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by Hart et al. are also contradicted by reports of an increased 
proportion of CD8+ T-cells and CD16+ NK cells in the periph-
eral blood of patients undergoing revision arthroplasty due to 
aseptic loosening (Case et al. 2000).
Immunological reactions around arthroplasty 
implants
Several  reports  have  described  predominantly  lymphocytic 
infiltrates in the neo-capsule of revised metal-on-metal THAs, 
consisting mainly of CD3+ T-cells and CD20+ B-cells, but also 
containing considerable numbers of macrophages (Davies et 
al. 2005, Willert et al. 2005, Witzleb et al. 2007). This type 
of infiltrate appears to be rather specific for metal-on-metal 
bearings; it is quite distinct from infiltrates that can be seen 
around metal-on-polyethylene THAs or in situations involv-
ing conventional deep infection. In addition, expression of 
interferon-γ and the presence of activated T-cells have been 
described  in  the  pseudomembrane  surrounding  implants 
(Weyand et al. 1998). An immunohistochemical analysis of 
loose orthopedic implants with a cobalt-chromium compo-
nent revealed an elevated level of HLA DR+ macrophages and 
enrichment of CD4+ and CD8+ T-cells at the bone-implant 
interface (al Saffar and Revell 1994).
It has also been reported that women with a metal-on-metal 
resurfacing arthroplasty are predisposed to development of 
periprosthetic pseudotumors with extensive connective tissue 
necrosis  and  mainly  lymphocytic  infiltration  (Pandit  et  al. 
2008). We therefore stratified our study population by sex but 
found no differences between the sexes. Thus, our findings 
cannot explain the observed predisposition of women regard-
ing this phenomenon.
Sensitization to heavy metal ions after THA
Sensitization to various heavy metals after THA was already 
described  after  the  use  of  first-generation  metal-on-metal 
arthroplasties during the 1970s, but even today it “… remains 
uncertain whether the loosening causes the sensitization or 
vice versa” (Elves et al. 1975). Even with the use of modern 
metal-on-metal THA, immunological reactions to heavy metal 
ions are known to occur, as increased lymphocytic reactivity 
to both cobalt and nickel has been described in patients with 
metal-on-metal  articulations  (Hallab  et  al.  2004).  Further-
more, the lymphocytes of patients reacting to chromium more 
readily release interferon-γ (Hallab et al. 2008). 
The mechanisms behind the immunological reactions after 
metal-on-metal THA are not yet understood. Macrophages at 
the prosthesis/tissue interface are considered to present hap-
tenic metal ions in the context of self peptides (metal ion-
altered self) as antigens in combination with MHC class II 
molecules, leading to T-cell priming. The mediation of metal 
sensitization via T-cells has been suggested by several authors: 
T-cell infiltrates at the implant interface suggest an associa-
tion with type IV, cell-mediated sensitivity (Lalor et al. 1990), 
and CD3- and CD28-related signaling was observed in T-cells 
after exposure to cobalt/chromium-particles in vitro (Ogun-
wale et al. 2009).
There was a correlation between the percentage of HLA 
DR+ CD8+ T-cells in our study and the concentration of chro-
mium  and  cobalt,  although  the  correlation  was  weak.  We 
therefore speculate that heavy metal ions released from the 
implant may be processed on HLA DR+ CD8+ T-cells—either 
like superantigens by forming and stabilizing bridges between 
the T-cell receptor and MHC class II molecules, or as neoanti-
gens created by metal-protein interactions. We did not analyze 
cytokine release and cellular activation markers, however.
Limitations of the study
The analysis of immunological parameters was added as a 
secondary endpoint after patient recruitment had been com-
pleted, and was not included in the primary study protocol. 
The present study, based on only 36 individuals eligible for 
immunological analysis, was therefore open to type-II error. 
At the same time, small cohorts are vulnerable to outliers, and 
type-I errors can therefore also occur. Approximately equal 
numbers were lost to follow-up or were excluded from final 
analysis in both study groups; we therefore believe that there 
was no selection bias. Taken together, our findings must be 
regarded as being derived from a pilot study on a small cohort 
of patients.
Conclusion
Our study indicates that elevated chromium and cobalt con-
centrations after metal-on-metal THA correlate with immuno-
logical reactions, reflected by an elevation in HLA DR+ CD8+ 
T-cells and a decrease in the percentage of B-cells. We cur-
rently have no evidence that the elevation of this subtype of 
lymphocytes is the cause of allergic reactions, aseptic loosen-
ing, or periprosthetic pseudotumors that have been described 
after metal-on-metal arthroplasty. Future studies investigating 
a possible association between these phenomena must be per-
formed on larger groups of patients.
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